1. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson’s disease.
Mov Disord. 2008;23:183-189 quiz 313.
2. Ishihara L, Brayne C. A systematic review of depression and mental illness preceding Parkinson’s disease.
Acta Neurol Scand. 2006;113:211-220.
3. Stanković I, Stefanova E, Žiropadja L, Mijajlović M, Pavlović A, Kostić VS. Transcranial midbrain sonography and depressive symptoms in patients with Parkinson’s disease.
J Neurol. 2015;262:689-695.
4. Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, et al. Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography.
J Neurol Neurosurg Psychiatry. 1997;63:590-596.
5. Krogias C, Walter U. Transcranial sonography findings in depression in association with psychiatric and neurologic diseases: a review.
J Neuroimaging. 2016;26:257-263.
6. Cho JW, Baik JS, Lee MS. Mesencephalic midline change on transcranial sonography in early Parkinson’s disease patients with depression.
J Neurol Sci. 2011;310:50-52.
7. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases.
J Neurol Neurosurg Psychiatry. 1992;55:181-184.
8. Ghourchian S, Zamani B, Poorkosary K, Malakouti SK, Rohani M. Raphe nuclei echogenicity changes in major depression.
Med J Islam Repub Iran. 2014;28:9.
9. Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R. Parkinson’s disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Brain. 2007;130(Pt 7):1799-1807.
10. Hornung JP. The human raphe nuclei and the serotonergic system.
J Chem Neuroanat. 2003;26:331-343.
11. Peyron C, Petit JM, Rampon C, Jouvet M, Luppi PH. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods.
Neuroscience. 1998;82:443-468.
12. Michelsen KA, Prickaerts J, Steinbusch HW. The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer’s disease.
Prog Brain Res. 2008;172:233-264.
13. Tiger M, Ruck C, Forsberg A, Varrone A, Lindefors N, Halldin C, et al. Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder.
Psychiatry Res. 2014;223:164-170.
14. Seidel G, Kaps M, Gerriets T. Potential and limitations of transcranial color-coded sonography in stroke patients.
Stroke. 1995;26:2061-2066.
15. Lien LM, Chen WH, Chen JR, Chiu HC, Tsai YF, Choi WM, et al. Comparison of transcranial color-coded sonography and magnetic resonance angiography in acute ischemic stroke.
J Neuroimaging. 2001;11:363-368.
16. Itoh T, Matsumoto M, Handa N, Maeda H, Hougaku H, Hashimoto H, et al. Rate of successful recording of blood flow signals in the middle cerebral artery using transcranial Doppler sonography.
Stroke. 1993;24:1192-1195.
17. Kwon JH, Kim JS, Kang DW, Bae KS, Kwon SU. The thickness and texture of temporal bone in brain CT predict acoustic window failure of transcranial Doppler.
J Neuroimaging. 2006;16:347-352.
18. Becker G, Berg D, Lesch KP, Becker T. Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings.
Int J Neuropsychopharmacol. 2001;4:21-31.
19. Walter U, Prudente-Morrissey L, Herpertz SC, Benecke R, Hoeppner J. Relationship of brainstem raphe echogenicity and clinical findings in depressive states.
Psychiatry Res. 2007;155:67-73.